Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.1 USD | -3.57% | +2.27% | +61.35% |
05-09 | ImmunityBio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
05-07 | ImmunityBio Shares Rise After Completion of Drug Substance Manufacturing for Cancer Treatment | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+61.35% | 5.6B | |
+7.52% | 113B | |
+11.38% | 106B | |
+1.46% | 22.27B | |
-12.64% | 22.22B | |
-5.10% | 19.43B | |
-37.85% | 17.87B | |
-8.58% | 17.24B | |
+7.77% | 14.29B | |
+37.41% | 12.52B |
- Stock Market
- Equities
- IBRX Stock
- News ImmunityBio, Inc.
- Piper Sandler Adjusts Price Target on ImmunityBio to $6 From $5, Maintains Neutral Rating